Rosales-Castillo Antonio, Jiménez-Guerra Gemma, Ruiz-Gómez Lara, Expósito-Ruíz Manuela, Navarro-Marí José María, Gutiérrez-Fernández José
Servicio de Medicina Interna, Virgen de las Nieves University Hospital & Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Avenida de las Fuerzas Armadas 2, 18014 Granada, Spain.
Program in Clinical Medicine and Public Health, University of Granada & Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18016 Granada, Spain.
J Clin Med. 2022 Mar 1;11(5):1348. doi: 10.3390/jcm11051348.
The detection of emerging pathogens responsible for genitourinary infections has increased with technological advances. We conducted a systematic review of publications on the involvement of these microorganisms in genitourinary samples, and we also investigated their presence and antibiotic susceptibility in samples from patients at our regional hospital (Granada, Spain). The MEDLINE database was searched up to 31 December 2020, and a cross-sectional descriptive study was performed of results obtained in urine samples and genital exudates from January 2016 through December 2019. The review highlighted the frequent involvement of in genital infections, while the data on other microorganisms were consistent with findings in our patient series. The emerging microorganisms most often responsible for urinary tract infections were (58.5%) and (23.6%) in females, and (32.3%), (18.6%), and spp. (16.9%) in males; those most frequently reported in genital infections were (36.4%) in females and (32.2%) and (35.6%) in males. In general, emerging pathogens are resistant to conventional antibiotics such as penicillin. However, there has also been an increase in beta-lactam resistance by the group and spp. The systematic review showed that emerging microorganisms are responsible for only a small percentage of genitourinary infections but are of major clinical interest, with a predominance of the group, , spp., spp., and spp. in urine samples and of and in genital samples. Given the increasing resistance to antibiotics empirically prescribed in patients with genitourinary infections, it is recommended to create an antibiogram in all cases.
随着技术进步,对引起泌尿生殖系统感染的新型病原体的检测有所增加。我们对有关这些微生物在泌尿生殖系统样本中的研究报告进行了系统综述,并且还调查了它们在我们地区医院(西班牙格拉纳达)患者样本中的存在情况及抗生素敏感性。检索MEDLINE数据库至2020年12月31日,并对2016年1月至2019年12月期间尿液样本和生殖器分泌物中获得的结果进行了横断面描述性研究。该综述强调了[此处原文缺失相关微生物名称]在生殖器感染中经常出现,而关于其他微生物的数据与我们患者系列中的发现一致。女性中最常引起尿路感染的新型微生物是[此处原文缺失相关微生物名称](58.5%)和[此处原文缺失相关微生物名称](23.6%),男性中是[此处原文缺失相关微生物名称](32.3%)、[此处原文缺失相关微生物名称](18.6%)和[此处原文缺失相关微生物名称]属(16.9%);生殖器感染中最常报告的是女性中的[此处原文缺失相关微生物名称](36.4%)以及男性中的[此处原文缺失相关微生物名称](32.2%)和[此处原文缺失相关微生物名称](35.6%)。一般来说,新型病原体对青霉素等传统抗生素具有耐药性。然而,[此处原文缺失相关微生物名称]组和[此处原文缺失相关微生物名称]属的β-内酰胺耐药性也有所增加。系统综述表明,新型微生物仅占泌尿生殖系统感染的一小部分,但具有重要的临床意义,在尿液样本中以[此处原文缺失相关微生物名称]组、[此处原文缺失相关微生物名称]、[此处原文缺失相关微生物名称]属、[此处原文缺失相关微生物名称]属和[此处原文缺失相关微生物名称]属为主,在生殖器样本中以[此处原文缺失相关微生物名称]和[此处原文缺失相关微生物名称]为主。鉴于泌尿生殖系统感染患者对经验性使用的抗生素耐药性不断增加,建议在所有病例中都进行药敏试验。